CLINICAL_TRIALS
trial_result
· 2023-12-20
Clinical Trial Update: A Study of RVT-1401 in Myasthenia Gravis (MG) Patients [Phase 2]
Summary
Phase 2 trial of RVT-1401 in Myasthenia Gravis has been completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Immunovant Sciences GmbH | Conditions: Myasthenia Gravis | Phase 2 | Status: COMPLETED | Results posted: 2023-12-20